Detalhe da pesquisa
1.
MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo.
Cell Stem Cell
; 24(4): 579-591.e12, 2019 04 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30853557
2.
MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo.
Cell Stem Cell
; 26(3): 458, 2020 Mar 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32142664